BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Blackstone to Sell Stake in Xinrong Best Medical, Deal Could Fetch $400M

  The PE firm made the investment just three years ago.

  November 7, 2017

   · 

  1 min read
• Business

  ZIVO Bioscience Annual Shareholder Meeting and Conference Call Slated for November 8, 2017 in Detroit, Michigan

  The Company’s management will share its progress on various research and product development efforts over the past year.

  November 7, 2017

   · 

  2 min read
• 

  Deals

  Cantrell Drug Company Files for Chapter 11 Bankruptcy

  Nearly four months after issuing a voluntary recall of all lots of unexpired sterile drug products, Cantrell Drug Company has filed for bankruptcy.

  November 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Boston Scientific Recalls Certain Sizes of Eluvia, Innova Stents

  The company is pulling these particular devices due to the number of complaints that it received relating to partial stent deployment.

  November 7, 2017

   · 

  1 min read
• Business

  Xencor Reports Third Quarter 2017 Financial Results and Provides Clinical Pipeline Update

  “Our third quarter results highlight the promise of our XmAb technology to create a broad pipeline of engineered antibodies with improved performance across a range of unmet needs,” said Bassil Dahiyat, Ph.D., president and chief executive officer of Xencor.

  November 7, 2017

   · 

  15 min read
• Business

  NeuroVive Board Chair Resigns, New Chair Elected

  NeuroVive announces that Gregory Batcheller resigned as Chair of the NeuroVive Pharmaceutical AB Board effective midnight November 6, 2017.

  November 7, 2017

   · 

  4 min read
• Business

  Innovus Pharmaceuticals to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 14, 2017

  The Company will host a conference call at 4:15 p.m. ET/1:15 p.m. PT on the same day to discuss the financial results and recent business developments.

  November 7, 2017

   · 

  3 min read
• Policy

  Axonics Receives IDE Clearance From U.S. FDA to Conduct a Pivotal Study With Its Sacral Neuromodulation System for the Treatment of Urinary Dysfunction

  Axonics announced the U.S. Food & Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) in accordance with 21 CFR 812 regulations allowing Axonics to conduct a pivotal study designed to gain FDA approval in the United States.

  November 7, 2017

   · 

  3 min read
• Business

  Veracyte Announces Third Quarter 2017 Financial Results

  For the third quarter of 2017, revenue was $17.5 million, compared to $18.6 million for the third quarter of 2016.

  November 7, 2017

   · 

  12 min read
• Business

  ERYTECH Reports Third Quarter 2017 Financial Results and Provides Business Update

  Net loss for the nine-month period ended September 30, 2017 was €20.8 million, compared to €16.1 million for the same period in the prior year.

  November 7, 2017

   · 

  13 min read